Although HCC progression was phenotypically suppressed in SHBG mice compared with that in WT mice, which is similar to our published data [28], EE2 could expose SHBG mice to HCC risk by triggering markedly pronounced hepatitis, fibrosis, and compensatory proliferation with AR activation. This evidence concerns the gene AR and hepatocellular carcinoma.